GSK ranks seventh at 71.88 in WCRC’s UK 100. Bupa ranks 41st at 65.92. Both sit in Healthcare & Pharma. Their provisional scores on Consumer Trust & Sentiment are 68 and 66 respectively. At a 26% weight, that difference contributes 0.52 points to the 5.96-point overall spread. The product, innovation and delivery gap of ten points contributes two points.
The figures open a question about how a healthcare brand earns trust. A clinician evaluating a medicines company may be concerned about evidence and reliable supply. A member considering a health services brand may care more about what their plan covers and how readily they can get help. Those expectations call for different survey questions.
For a valid comparison, start with a common audience, a defined decision and a question each brand can reasonably answer. When those conditions are missing, use the scorecards to examine each brand’s relationship with its own stakeholders. Claims about clinical performance or patient outcomes would require separate evidence.
Gsk scorecard · Bupa scorecard · UK 100 ranking · WCRC Power Score methodology